| Vascular actions of relaxin: nitric oxide and beyond CH Leo, M Jelinic, HH Ng, SA Marshall, J Novak, M Tare, KP Conrad, ... British journal of pharmacology 174 (10), 1002-1014, 2017 | 101 | 2017 |
| Hydrogen sulfide as a vasculoprotective factor E Streeter, HH Ng, JL Hart Medical gas research 3, 1-7, 2013 | 69 | 2013 |
| Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro. MR Al-Magableh, BK Kemp-Harper, HH Ng, AA Miller, JL Hart Naunyn-Schmiedeberg's archives of pharmacology 387, 67-74, 2014 | 68 | 2014 |
| Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways HH Ng, M Shen, CS Samuel, J Schlossmann, RG Bennett Molecular and cellular endocrinology 487, 59-65, 2019 | 61 | 2019 |
| Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes HH Ng, CH Leo, D Prakoso, C Qin, RH Ritchie, LJ Parry Scientific Reports 7 (1), 39604, 2017 | 55 | 2017 |
| Serelaxin: a novel therapeutic for vascular diseases CH Leo, M Jelinic, HH Ng, M Tare, LJ Parry Trends in pharmacological sciences 37 (6), 498-507, 2016 | 48 | 2016 |
| Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice HH Ng, M Jelinic, LJ Parry, CH Leo American Journal of Physiology-Heart and Circulatory Physiology 309 (2 …, 2015 | 48 | 2015 |
| Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta HH Ng, CH Leo, LJ Parry Pharmacological research 107, 220-228, 2016 | 43 | 2016 |
| Time‐dependent activation of prostacyclin and nitric oxide pathways during continuous iv infusion of serelaxin (recombinant human H2 relaxin) CH Leo, M Jelinic, HH Ng, M Tare, LJ Parry British journal of pharmacology 173 (6), 1005-1017, 2016 | 41 | 2016 |
| Relaxin as a therapeutic target for the cardiovascular complications of diabetes HH Ng, CH Leo, LJ Parry, RH Ritchie Frontiers in Pharmacology 9, 360916, 2018 | 40 | 2018 |
| Chronic NaHS treatment decreases oxidative stress and improves endothelial function in diabetic mice HH Ng, GS Yildiz, JM Ku, AA Miller, OL Woodman, JL Hart Diabetes and Vascular Disease Research 14 (3), 246-253, 2017 | 37 | 2017 |
| 1, 4-Anhydro-4-seleno-d-talitol (SeTal) protects endothelial function in the mouse aorta by scavenging superoxide radicals under conditions of acute oxidative stress HH Ng, CH Leo, K O'Sullivan, SA Alexander, MJ Davies, CH Schiesser, ... Biochemical Pharmacology 128, 34-45, 2017 | 33 | 2017 |
| B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin) SA Marshall, K O'Sullivan, HH Ng, RAD Bathgate, LJ Parry, MA Hossain, ... European Journal of Pharmacology 807, 190-197, 2017 | 32 | 2017 |
| Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries N Kahlberg, CX Qin, J Anthonisz, E Jap, HH Ng, M Jelinic, LJ Parry, ... Pharmacological Research 111, 325-335, 2016 | 29 | 2016 |
| Relaxin reduces endothelium‐derived vasoconstriction in hypertension: Revealing new therapeutic insights CH Leo, HH Ng, SA Marshall, M Jelinic, T Rupasinghe, C Qin, ... British Journal of Pharmacology 177 (1), 217-233, 2020 | 26 | 2020 |
| Serelaxin treatment reduces oxidative stress and increases aldehyde dehydrogenase-2 to attenuate nitrate tolerance CH Leo, DT Fernando, L Tran, HH Ng, SA Marshall, LJ Parry Frontiers in Pharmacology 8, 141, 2017 | 25 | 2017 |
| Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis EM Kaftanovskaya, HH Ng, M Soula, B Rivas, C Myhr, BA Ho, ... The FASEB Journal 33 (11), 12435, 2019 | 21 | 2019 |
| Recent developments in relaxin mimetics as therapeutics for cardiovascular diseases CH Leo, M Jelinic, HH Ng, LJ Parry, M Tare Current Opinion in Pharmacology 45, 42-48, 2019 | 19 | 2019 |
| Annexin‐A1 deficiency exacerbates pathological remodelling of the mesenteric vasculature in insulin‐resistant, but not insulin‐deficient, mice M Jelinic, N Kahlberg, CH Leo, HH Ng, S Rosli, M Deo, M Li, S Finlayson, ... British Journal of Pharmacology 177 (7), 1677-1691, 2020 | 14 | 2020 |
| Relaxin elicits renoprotective actions accompanied by increasing bile acid levels in streptozotocin-induced diabetic mice CH Leo, JLM Ou, ES Ong, CX Qin, RH Ritchie, LJ Parry, HH Ng Biomedicine & Pharmacotherapy 162, 114578, 2023 | 8 | 2023 |
